Hisako Ono

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 1

Top Topics

Metastatic Breast Cancer

Inflammatory Response

Endoplasmic Reticulum Stress

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Hisako Ono, Mano Horinaka, Mamiko Sukeno, Mie Morita, Shusuke Yasuda, Emi Nishimoto, Eiichi Konishi, Toshiyuki Sakai
Novel RAF/MEK inhibitor CH5126766/VS-6766 has efficacy in combination with eribulin for the treatment of triple-negative breast cancer. Cancer science 112 (10) (2021)